Logo

ABI to Distribute Eksigent s Tempo Liquid Chromatography System

Jan 10, 2006

NEW YORK, Jan. 10 (GenomeWeb News) - Eksigent Technologies signed a distribution agreement with Applied Biosystems for a line of high performance liquid chromatography systems, the company said today.

 

Under the agreement, Eksigent will integrate its Microfluidic Flow Control technology with Applied Biosystems/MDS SCIEX mass spectrometers to create the Tempo liquid chromatography systems. The line includes platforms for nano LC, high-throughput micro LC and an LC-MALDI deposition system.

 

Applied Biosystems/MDS SCIEX will service and sell the resulting line as front ends to their mass spectrometers, Eksigent said.

 

Applied Biosystems/MDS SCIEX is a joint venture between ABI, an Applera business, and MDS SCIEX, a MDS division.

 

Additional details were not disclosed.

 

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.